LeMaitre Vascular (LMAT) Competitors $87.07 -0.42 (-0.48%) As of 12:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LMAT vs. IRTC, BLCO, GKOS, TMDX, SLNO, NVST, LIVN, WRBY, INSP, and EYEShould you be buying LeMaitre Vascular stock or one of its competitors? The main competitors of LeMaitre Vascular include iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), and National Vision (EYE). These companies are all part of the "medical equipment" industry. LeMaitre Vascular vs. Its Competitors iRhythm Technologies Bausch + Lomb Glaukos TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Inspire Medical Systems National Vision iRhythm Technologies (NASDAQ:IRTC) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation. Which has stronger valuation & earnings, IRTC or LMAT? LeMaitre Vascular has lower revenue, but higher earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRhythm Technologies$657.23M8.71-$113.29M-$2.93-60.83LeMaitre Vascular$219.86M8.97$44.04M$2.0642.27 Do insiders and institutionals have more ownership in IRTC or LMAT? 84.6% of LeMaitre Vascular shares are owned by institutional investors. 1.1% of iRhythm Technologies shares are owned by company insiders. Comparatively, 9.5% of LeMaitre Vascular shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is IRTC or LMAT more profitable? LeMaitre Vascular has a net margin of 20.08% compared to iRhythm Technologies' net margin of -14.06%. LeMaitre Vascular's return on equity of 13.67% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets iRhythm Technologies-14.06% -90.03% -8.52% LeMaitre Vascular 20.08%13.67%9.14% Does the media prefer IRTC or LMAT? In the previous week, iRhythm Technologies had 7 more articles in the media than LeMaitre Vascular. MarketBeat recorded 13 mentions for iRhythm Technologies and 6 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.06 beat iRhythm Technologies' score of 0.59 indicating that LeMaitre Vascular is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 4 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LeMaitre Vascular 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer IRTC or LMAT? iRhythm Technologies currently has a consensus price target of $172.17, indicating a potential downside of 3.40%. LeMaitre Vascular has a consensus price target of $97.60, indicating a potential upside of 12.09%. Given LeMaitre Vascular's higher probable upside, analysts clearly believe LeMaitre Vascular is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 1 Sell rating(s) 2 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.79LeMaitre Vascular 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more volatility & risk, IRTC or LMAT? iRhythm Technologies has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. SummaryLeMaitre Vascular beats iRhythm Technologies on 11 of the 17 factors compared between the two stocks. Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LMAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LMAT vs. The Competition Export to ExcelMetricLeMaitre VascularMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.97B$10.71B$6.13B$10.51BDividend Yield0.91%1.86%5.51%4.67%P/E Ratio42.2722.2285.5226.80Price / Sales8.9727.52585.10183.02Price / Cash36.7825.6126.3031.10Price / Book5.803.4613.166.63Net Income$44.04M$210.63M$3.30B$276.44M7 Day Performance-0.50%1.82%4.71%2.93%1 Month Performance-10.69%1.40%8.36%9.95%1 Year Performance-2.72%-5.70%87.42%39.62% LeMaitre Vascular Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LMATLeMaitre Vascular3.9878 of 5 stars$87.07-0.5%$97.60+12.1%-4.5%$1.97B$219.86M42.27490News CoveragePositive NewsIRTCiRhythm Technologies1.149 of 5 stars$169.50-0.8%$167.50-1.2%+180.2%$5.49B$591.84M-57.852,000BLCOBausch + Lomb1.8799 of 5 stars$14.98+3.3%$15.56+3.9%-21.7%$5.13B$4.79B-19.2013,500Analyst ForecastGKOSGlaukos4.5087 of 5 stars$81.24+1.7%$123.58+52.1%-33.9%$4.58B$383.48M-49.24780TMDXTransMedics Group3.1373 of 5 stars$112.64-1.1%$125.40+11.3%-18.0%$3.88B$441.54M58.36210Positive NewsSLNOSoleno Therapeutics4.1779 of 5 stars$68.16+4.9%$115.09+68.9%+17.8%$3.45BN/A-16.4630Analyst ForecastNVSTEnvista3.7019 of 5 stars$20.22-0.7%$20.92+3.5%+9.6%$3.38B$2.51B63.1712,300LIVNLivaNova2.4911 of 5 stars$52.33-2.1%$59.71+14.1%-2.2%$2.92B$1.25B-13.452,900News CoverageWRBYWarby Parker1.7858 of 5 stars$27.69+0.3%$24.06-13.1%+57.8%$2.90B$771.32M-395.513,780News CoveragePositive NewsAnalyst ForecastINSPInspire Medical Systems4.842 of 5 stars$75.46-2.3%$154.43+104.6%-64.5%$2.28B$802.80M43.621,246EYENational Vision2.3556 of 5 stars$29.24+2.5%$24.73-15.4%+166.3%$2.26B$1.82B-162.4413,411Positive News Related Companies and Tools Related Companies IRTC Alternatives BLCO Alternatives GKOS Alternatives TMDX Alternatives SLNO Alternatives NVST Alternatives LIVN Alternatives WRBY Alternatives INSP Alternatives EYE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LMAT) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LeMaitre Vascular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
